Menu
GWAS Study

Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure.

Rasooly D, Peloso GM, Pereira AC et al.

37429843 PubMed ID
GWAS Study Type
1266315 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RD
Rasooly D
PG
Peloso GM
PA
Pereira AC
DH
Dashti H
GC
Giambartolomei C
WE
Wheeler E
AN
Aung N
FB
Ferolito BR
PM
Pietzner M
FE
Farber-Eger EH
WQ
Wells QS
KN
Kosik NM
GL
Gaziano L
PD
Posner DC
BA
Bento AP
HQ
Hui Q
LC
Liu C
AK
Aragam K
WZ
Wang Z
CB
Charest B
HJ
Huffman JE
WP
Wilson PWF
PL
Phillips LS
WJ
Whittaker J
MP
Munroe PB
PS
Petersen SE
CK
Cho K
LA
Leach AR
MM
Magariños MP
GJ
Gaziano JM
LC
Langenberg C
SY
Sun YV
JJ
Joseph J
CJ
Casas JP
Chapter II

Abstract

Summary of the research findings

We conduct a large-scale meta-analysis of heart failure genome-wide association studies (GWAS) consisting of over 90,000 heart failure cases and more than 1 million control individuals of European ancestry to uncover novel genetic determinants for heart failure. Using the GWAS results and blood protein quantitative loci, we perform Mendelian randomization and colocalization analyses on human proteins to provide putative causal evidence for the role of druggable proteins in the genesis of heart failure. We identify 39 genome-wide significant heart failure risk variants, of which 18 are previously unreported. Using a combination of Mendelian randomization proteomics and genetic cis-only colocalization analyses, we identify 10 additional putatively causal genes for heart failure. Findings from GWAS and Mendelian randomization-proteomics identify seven (CAMK2D, PRKD1, PRKD3, MAPK3, TNFSF12, APOC3 and NAE1) proteins as potential targets for interventions to be used in primary prevention of heart failure.

90,653 European ancestry cases, 1,188,957 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1266315
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.